| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Revenue | $4.1B | $4.2B |
| Cost of Revenue | $3.9B | $4.0B |
| Gross Profit | $0.2B | $0.2B |
| R&D Expense | — | — |
| SG&A Expense | — | — |
| Operating Income | $0.1B | $0.0B |
| Net Income | $-0.0B | $-0.2B |
| EPS (Basic) | $-0.39 | $-2.67 |
| EPS (Diluted) | $-0.39 | $-2.67 |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Total Assets | $2.7B | $2.8B |
| Current Assets | $0.9B | $0.8B |
| Cash & Equivalents | $0.1B | $0.0B |
| Total Liabilities | $3.2B | $3.2B |
| Current Liabilities | $0.8B | $0.9B |
| Stockholders' Equity | $-0.7B | $-0.7B |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Operating Cash Flow | $0.1B | $-0.0B |
| Investing Cash Flow | $0.0B | $-0.1B |
| Capital Expenditures | $0.1B | $0.1B |
| Financing Cash Flow | $0.0B | $0.2B |